Can You Restart Concerta 27 mg at the Same Dose?
Yes, you can restart Concerta 27 mg at the same dose if the patient was previously stable on this medication, though the duration of discontinuation and clinical context should guide your decision. The FDA label does not specify a mandatory washout period or requirement to retitrate after a treatment interruption 1.
Key Considerations for Restarting
Duration of Discontinuation Matters
- Short interruptions (days to weeks): Resume at the previous effective dose
- Longer interruptions (months): Consider clinical reassessment but can still restart at prior dose if:
- Patient was previously stable and well-controlled
- No significant weight changes occurred
- No new cardiac or psychiatric conditions developed
- Previous dose was well-tolerated
Pretreatment Reassessment Required
Before restarting, the FDA label mandates you assess for 1:
- Cardiac disease: Obtain history of structural cardiac abnormalities, family history of sudden death or ventricular arrhythmia, and perform physical exam
- Tics or Tourette's syndrome: Evaluate family history and clinically assess for motor or verbal tics
Dosing Context for 27 mg
The 27 mg strength exists specifically as an intermediate dose between 18 mg and 36 mg 1. If the patient was previously titrated to and maintained on 27 mg, this indicates:
- They required more than the starting 18 mg dose
- They didn't need the full 36 mg dose
- This was their optimal therapeutic dose
Clinical Algorithm for Restart Decision
Restart at 27 mg if:
- Previous treatment duration was adequate (weeks to months)
- Patient had documented clinical response at this dose
- Discontinuation was brief (< 3 months) or patient remained symptomatic off medication
- No new contraindications emerged
- Weight remains stable (within 10% of previous)
Consider lower starting dose (18 mg) if:
- Discontinuation exceeded 6 months
- Significant weight loss occurred (>10%)
- Patient is now younger than 13 years and dose exceeds weight-based recommendations
- Previous tolerability concerns existed
- Uncertainty about adherence or response at prior dose
Important Safety Caveats
Monitoring After Restart
Guidelines recommend systematic assessment during any dose adjustment phase 2:
- Weekly contact (phone or visit) during first 2-4 weeks
- Monitor for side effects: insomnia, anorexia, headaches, social withdrawal, tics, weight loss
- Obtain parent AND teacher ratings of ADHD symptoms
- Monthly visits until symptoms stabilized
The Tolerance Question
Research shows methylphenidate remains effective after long-term use without significant tolerance 3. A discontinuation study found that patients who stopped methylphenidate after 2+ years of treatment showed significant deterioration compared to those who continued, confirming ongoing efficacy. This suggests that restarting at a previously effective dose is pharmacologically sound.
Common Pitfall to Avoid
Do not automatically assume you must start at 18 mg and retitrate. The FDA label's dosing tables for "patients new to methylphenidate" apply to treatment-naïve patients, not those restarting after a gap 1. Unnecessary retitration delays symptom control and increases burden on families.
Documentation Recommendation
Document in your note:
- Previous dose and duration of treatment
- Reason for discontinuation
- Clinical status during the gap
- Rationale for dose selection on restart
- Cardiac and tic screening completed
The 27 mg dose can be safely restarted without retitration in most clinical scenarios where the patient was previously stable on this dose.